Sheree Lacoste, NP
Acute Care · Foley, ALNPI 1730426925
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 392 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 392 payments — averaging $29.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Incyte Corporation$920
- Sun Pharmaceutical Industries Inc.$804
- Dermavant Sciences, Inc.$752
- Sanofi$709
- plus $5K from 26 others
What the payments were for
- Food & beverage$10,93995%
- Education$5395%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 90 | $2,474 |
| Johnson & Johnson | 44 | $1,251 |
| Incyte Corporation | 24 | $920 |
| Sun Pharmaceutical Industries Inc. | 36 | $804 |
| Dermavant Sciences, Inc. | 27 | $752 |
| Sanofi | 15 | $709 |
| Regeneron Healthcare Solutions, Inc. | 12 | $530 |
| Novartis | 19 | $400 |
| Galderma Laboratories, L.p. | 10 | $388 |
| LEO Pharma Inc. | 16 | $368 |
| E.r. Squibb & Sons, L.L.C. | 17 | $364 |
| Arcutis Biotherapeutics, Inc. | 6 | $311 |
| Lilly USA, LLC | 8 | $256 |
| Pfizer | 12 | $234 |
| Amgen | 7 | $226 |
| Paratek Pharmaceuticals, Inc. | 5 | $173 |
| Janssen Scientific Affairs, LLC | 2 | $169 |
| Mallinckrodt Hospital Products Inc. | 5 | $142 |
| UCB, Inc. | 6 | $131 |
| Organon | 8 | $122 |
| AstraZeneca | 1 | $121 |
| Kerecis Limited | 5 | $115 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Novo Nordisk | 1 | $83 |
| Bayer | 1 | $70 |
| Journey Medical Corporation | 3 | $65 |
| Boehringer Ingelheim | 3 | $60 |
| Almirall LLC | 2 | $47 |
| Fresenius Kabi USA, LLC | 2 | $30 |
| Mayne Pharma Commercial LLC | 2 | $27 |
| Dexcom, Inc. | 1 | $24 |
| Chiesi USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,477 in reported general payments places this provider in the 95th percentile of 711 acute care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $51,761 |
| Clobetasol Propionate | 111 | $4,365 |
| Fluorouracil | 60 | $4,087 |
| Ketoconazole | 190 | $3,324 |
| Tacrolimus | 18 | $2,253 |
| Doxycycline Hyclate | 92 | $1,784 |
| Metronidazole | 25 | $1,482 |
| Triamcinolone Acetonide | 126 | $1,320 |
| Ammonium Lactate | 65 | $1,300 |
| Clindamycin Phosphate | 31 | $994 |
| Permethrin | 13 | $789 |
| Terbinafine Hcl | 45 | $277 |
| Mupirocin | 27 | $237 |
| Spironolactone | 12 | $220 |
| Nystatin | 19 | $218 |
Paid to pharmacies, not to this prescriber.
Other acute care in Foley
- Debra DavisFoley$31K
- Paige HarrisMontgomery$465K
- Coretta CollinsBirmingham$77K
- Leslie GastonMobile$22K
- Gwendolyn HooperTuscaloosa$16K
- Rachel PrytulaDothan$14K
- Jennifer UmbargerMobile$14K
- April KlarHuntsville$13K
- Cameron StephensonBirmingham$13K
- Jonathan McCraryBirmingham$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.